Evidence map›Paper›PMID 36537836›Full record

ArticleCPT: pharmacometrics & systems pharmacology2023

Variable or variate? A conundrum in pharmacometrics exposure-response models.

Ana-Marija Grisic, Karthik Venkatakrishnan, Jonathan French, Akash Khandelwal

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana-Marija GrisicThe Healthcare Business of Merck KGaA, Darmstadt, Germany.ORCID 0000-0002-1093-6879
Karthik VenkatakrishnanEMD Serono, Billerica, Massachusetts, USA.ORCID 0000-0003-4039-9813
Jonathan FrenchMetrum Research Group, Tariffville, Connecticut, USA.ORCID 0000-0001-9649-169X
Akash KhandelwalThe Healthcare Business of Merck KGaA, Darmstadt, Germany.ORCID 0000-0002-0472-7173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key elements of scientific writing-consistency and clarity-can be compromised in case of inaccurate use of methodological terms, especially in complex and multidisciplinary scientific fields. Such is the case in reports of pharmacometrics exposure-response analyses with the use of the terms univariate/multivariate and univariable/multivariable. This perspective outlines the issues in the use of these terms, clarifies their definitions, provides examples, and makes recommendations for authors, reviewers, and journals in the fields of clinical pharmacology and pharmacometrics.

Indexed as

Pharmacology, ClinicalHumansWriting

Identifiers

PMID36537836
PMCPMC9931432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.